A spontaneous point mutation in the single 23S rRNA gene of the thermophilic arachaeon Sulfolobus acidocaldarius confers multiple drug resistance.
Development of transformable vectors for thermophilic archaea requires the characterization of appropriate selectable marker genes. Many antibiotic inhibitors of protein biosynthesis are known to bind to rRNA; therefore, we screened 14 for their capacity to inhibit growth of the thermophilic archaeon Sulfolobus acidocaldarius. Carbomycin, celesticetin, chloramphenicol, puromycin, sparsomycin, tetracycline, and thiostrepton all inhibited growth by different degrees. Spontaneous drug-resistant mutants were isolated from plates containing celesticetin or chloramphenicol. Six mutants from each plate exhibited a C-2585-to-U transition in the peptidyl transferase loop of 23S rRNA (corresponding to C-2452 in Escherichia coli 23S rRNA). The single-site mutation also conferred resistance to carbomycin. The mutated 23S rRNA gene provides a potentially useful and dominant marker for a thermophilic archael vector.
Aagaard
C
C
Institute of Molecular Biology, Copenhagen University, Denmark.
Phan
H
H
Trevisanato
S
S
Garrett
R A
RA
D001483:Base Sequence; D002701:Chloramphenicol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple / Q000235:genetics*; D005798:Genes, Bacterial / Q000235:genetics*; D007933:Leucomycins / Q000494:pharmacology; D008034:Lincomycin / Q000031:analogs & derivatives / Q000494:pharmacology; D055231:Lincosamides; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D017354:Point Mutation / Q000235:genetics*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*; D011691:Puromycin / Q000494:pharmacology; D012338:RNA, Ribosomal, 23S / Q000235:genetics*; D013033:Sparsomycin / Q000494:pharmacology; D016945:Sulfolobus acidocaldarius / Q000235:genetics*; D013752:Tetracycline / Q000494:pharmacology; D013883:Thiostrepton / Q000494:pharmacology
D007933:Leucomycins; D055231:Lincosamides; D011500:Protein Synthesis Inhibitors; D012338:RNA, Ribosomal, 23S; C059423:carbomycin; D011691:Puromycin; D002701:Chloramphenicol; D013033:Sparsomycin; C004650:celesticetin A; D008034:Lincomycin; D013752:Tetracycline; D013883:Thiostrepton